← Back to Search

Enhanced Recovery After Surgery for Sarcoma

N/A
Recruiting
Led By Joshua Lawrenz, MD
Research Sponsored by Joshua Lawrenz
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients of all preoperative opioid status (naïve or dependent)
Any patient at Vanderbilt University Medical Center treated with surgical excision of a suspected extremity sarcoma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will show whether using the ERAS pathway can help patients undergoing surgery for extremity sarcoma recover better.

Who is the study for?
This trial is for adult patients over 17 years old at Vanderbilt University Medical Center who are about to have surgery for suspected sarcoma in an arm or leg. It's open to those who've never taken opioids and those who currently use them. Non-English speakers and patients not having surgery are excluded.Check my eligibility
What is being tested?
The study is testing a program called Enhanced Recovery After Surgery (ERAS) specifically designed for people getting surgical treatment for extremity sarcoma, which affects the limbs. The goal is to see if ERAS improves recovery outcomes after their operations.See study design
What are the potential side effects?
Since this trial focuses on a recovery pathway rather than a drug, traditional side effects aren't applicable. However, there may be risks associated with changes in postoperative care protocols that could affect patient comfort or recovery speed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My opioid use before surgery varies.
Select...
I had surgery at Vanderbilt for a suspected sarcoma in my arm or leg.
Select...
I am older than 17 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical outcomes - length of hospital stay
Clinical outcomes - opioid requirements
Clinical outcomes - perioperative complications (e.g. wound complications and 30-day readmission)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ERASExperimental Treatment1 Intervention
Administration of a perioperative non-narcotic, multimodal pain management pathway.
Group II: Non-ERAS (Conventional)Active Control1 Intervention
Administration of a conventional perioperative pain management pathway that consists of both narcotic and non-narcotic pain medications.

Find a Location

Who is running the clinical trial?

Joshua LawrenzLead Sponsor
Joshua Lawrenz, MD5.01 ReviewsPrincipal Investigator - Vanderbilt Medical Center
Vanderbilt-Ingram Cancer Center
5Patient Review
Dr. Smith was very kind and patient with me. They explained everything that was going to happen before they did it, which made me feel more comfortable.

Media Library

Enhanced Recovery After Surgery Clinical Trial Eligibility Overview. Trial Name: NCT04461171 — N/A
Sarcoma Research Study Groups: ERAS, Non-ERAS (Conventional)
Sarcoma Clinical Trial 2023: Enhanced Recovery After Surgery Highlights & Side Effects. Trial Name: NCT04461171 — N/A
Enhanced Recovery After Surgery 2023 Treatment Timeline for Medical Study. Trial Name: NCT04461171 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Up to how many participants can this experiment support?

"Yes, the information on clinicaltrials.gov attests that this medical experiment is actively seeking participants. It was initially posted in December 2020 and its most recent update happened July 8th 2022. The investigation requires 120 individuals to be recruited from a single location."

Answered by AI

Are there opportunities to join the trial at this time?

"As indicated on clinicaltrials.gov, the recruitment phase for this trial is ongoing; it was first published on December 14th 2020 and last modified on July 8th 2022."

Answered by AI
~20 spots leftby Dec 2024